Clinical TrialsSearch results
Number of results: 857
Recruiting
- A Phase 1b/2 Study of Oral HH2853 in Patients with Relapsed/Refractory Peripheral T-cell Lymphoma
- Peripheral T-cell Lymphoma
- Onishi Shintaro
- 2023-04-30
Recruiting
- A PHASE 3 OPEN-LABEL STUDY OF PTC923 (SEPIAPTERIN) IN PHENYLKETONURIA
- Phenylketonuria
- KOBAYASHI Tomoyo
- 2023-08-12
Recruiting
- A Phase 3, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Setmelanotide in Patients with Acquired Hypothalamic Obesity
- Acquired hypothalamic obesity (HO)
- Flaherty Jim
- 2024-02-22
Recruiting
- A phase II study of mFOLFOX6+Nivolumab in gastric cancer with severe peritoneal metastasis
- gastric cancer
- Masuishi Toshiki
- 2023-03-29
Recruiting
- A phase II trial for T-cell ALL
- T-cell acute lymphoblastic leukemia
- Sato Atsushi
- 2021-08-17
Recruiting
- A phase III randomized trial for B-cell precursor ALL
- B cell precursor Acute Lymphoblastic Leukemia
- Katsuyoshi Koh
- 2021-07-13
Recruiting
- A Phase III Study of FYU-981 in Hyperuricemic Pediatric Patients with or without Gout (Extension Study)
- Hyperuricemic pediatric patients with or without gout
- Fushimi Masahiko
- 2022-08-31
Recruiting
- A Phase III, Randomized, Open-Label, Multi-Center, Global Study of Volrustomig (MEDI5752) as Sequential Therapy Versus Observation in Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma, Who Have Not Progressed Following Definitive Concurrent Chemoradiotherapy (eVOLVE-HNSCC)
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Hibi Kazushige
- 2024-01-11
Recruiting
- A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advaneced or recurrent gastric cancer resistant to S-1
- Gastric Cancer
- ECRIN
- 2009-10-01
Recruiting
- A randomized phase II study comparing liposomal irinotecan + fluorouracil + levofolinate to FOLFIRINOX as second-line chemotherapy for pancreatic cancer (NUPAT-09 trial)
- Pancreatic cancer
- Maeda Osamu
- 2020-12-24